Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,494 | 212 | 44.7% |
| Consulting Fee | $5,375 | 1 | 43.8% |
| Travel and Lodging | $1,223 | 5 | 10.0% |
| Education | $188.52 | 3 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $7,168 | 30 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $829.32 | 26 | $0 (2024) |
| Janssen Biotech, Inc. | $651.30 | 19 | $0 (2024) |
| ABBVIE INC. | $544.09 | 22 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $526.09 | 19 | $0 (2024) |
| Dermavant Sciences, Inc. | $337.65 | 9 | $0 (2024) |
| LEO Pharma Inc. | $305.83 | 19 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $288.12 | 13 | $0 (2024) |
| Galderma Laboratories, L.P. | $273.70 | 6 | $0 (2024) |
| Amgen Inc. | $242.14 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,899 | 100 | Janssen Biotech, Inc. ($651.30) |
| 2023 | $8,892 | 102 | Incyte Corporation ($7,112) |
| 2022 | $488.76 | 19 | LEO Pharma Inc. ($98.01) |
All Payment Transactions
221 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.31 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.86 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.98 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.58 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.25 | General |
| Category: Dermatology | ||||||
| 12/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.86 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $37.30 | General |
| Category: Immunology | ||||||
| 11/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $34.75 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $38.50 | General |
| 11/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $33.26 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $9.26 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $8.90 | General |
| Category: Dermatology | ||||||
| 10/04/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: DERMATOLOGY | ||||||
| 10/04/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Inflammation | ||||||
| 10/01/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: DERMATOLOGY | ||||||
| 09/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $41.46 | General |
| Category: Immunology | ||||||
| 09/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.66 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/19/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $138.65 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 894 | 1,386 | $279,017 | $91,014 |
| 2022 | 9 | 330 | 528 | $81,355 | $29,359 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 192 | 273 | $59,378 | $19,974 | 33.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 123 | 154 | $44,672 | $16,243 | 36.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 114 | $35,222 | $12,385 | 35.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 106 | 106 | $30,498 | $9,071 | 29.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 86 | 93 | $25,982 | $7,761 | 29.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 85 | 106 | $17,413 | $4,925 | 28.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 13 | 13 | $11,867 | $3,944 | 33.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 21 | 25 | $10,644 | $3,825 | 35.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $13,583 | $3,360 | 24.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 62 | 326 | $5,687 | $2,248 | 39.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 28 | 36 | $4,908 | $1,805 | 36.8% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 11 | 11 | $7,464 | $1,603 | 21.5% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 21 | 33 | $4,752 | $1,594 | 33.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 12 | 12 | $4,011 | $1,469 | 36.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 14 | 17 | $2,608 | $781.89 | 30.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 19 | 34 | $328.00 | $25.92 | 7.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 83 | 98 | $21,250 | $7,987 | 37.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 45 | 49 | $14,351 | $5,372 | 37.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 49 | 53 | $14,216 | $4,863 | 34.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 24 | 28 | $8,580 | $3,339 | 38.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 28 | 28 | $7,423 | $2,799 | 37.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 40 | 45 | $7,436 | $1,850 | 24.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 29 | 191 | $3,232 | $1,319 | 40.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 15 | 19 | $2,558 | $922.71 | 36.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 17 | 17 | $2,309 | $907.97 | 39.3% |
About Dr. Yi Yang, MD
Dr. Yi Yang, MD is a Dermatology healthcare provider based in San Jose, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2018. The National Provider Identifier (NPI) number assigned to this provider is 1487141792.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yi Yang, MD has received a total of $12,280 in payments from pharmaceutical and medical device companies, with $2,899 received in 2024. These payments were reported across 221 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($5,494).
As a Medicare-enrolled provider, Yang has provided services to 1,224 Medicare beneficiaries, totaling 1,914 services with total Medicare billing of $120,373. Data is available for 2 years (2022–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location San Jose, CA
- Active Since 04/23/2018
- Last Updated 11/07/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1487141792
Products in Payments
- DUPIXENT (Biological) $876.07
- TREMFYA (Drug) $651.30
- VTAMA (Drug) $337.65
- OPZELURA (Drug) $332.51
- SKYRIZI (Biological) $321.15
- ADBRY (Biological) $305.83
- ILUMYA (Biological) $262.11
- COSENTYX (Drug) $260.20
- Otezla (Drug) $242.14
- RINVOQ (Biological) $222.94
- TALTZ (Drug) $221.63
- EUCRISA (Drug) $206.83
- Winlevi (Drug) $164.23
- Bimzelx (Biological) $102.15
- Sotyktu (Drug) $86.84
- Zoryve (Drug) $63.03
- VENACURE 1470 PRO (Device) $60.51
- Xeomin (Biological) $30.80
- XOLAIR (Drug) $27.92
- AMELUZ (Drug) $26.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in San Jose
Dr. Mychael Luu, M.d, M.D
Dermatology — Payments: $37,567
Sandra Yeh, M.d, M.D
Dermatology — Payments: $10,846
Michele Mak-Fung, M.d, M.D
Dermatology — Payments: $7,842
Michelle Cheng
Dermatology — Payments: $3,902
Mina Ally, M.d, M.D
Dermatology — Payments: $2,908
Dr. Sara Colby, Md, MD
Dermatology — Payments: $2,851